Actinomycin D inhibits cell proliferations and promotes apoptosis in osteosarcoma cells

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Actinomycin D (ActD) is a known transcription inhibitor inducing apoptosis in various cancer cells.
• The specific effects and molecular mechanisms of ActD on osteosarcoma cell survival remain largely uncharacterized.

Purpose of the Study:

• To investigate the impact of Actinomycin D on osteosarcoma cell proliferation and apoptosis.
• To elucidate the molecular mechanisms underlying ActD-induced effects in osteosarcoma cells.

Main Methods:

• Proliferation assays and Hoechst staining were performed on MG63 human osteosarcoma cells treated with ActD.
• Biochemical analyses, including western blotting, were used to assess protein levels (e.g., cleaved caspase-3, cyclin factors) and gene transcription.

Main Results:

• ActD treatment resulted in impaired proliferation and significant apoptosis in MG63 cells.
• Cleaved caspase-3 levels increased with ActD concentration and duration.
• Protein and mRNA levels of cyclin factors (cyclin A, D1, E) were reduced by ActD, suggesting cell cycle arrest.

Conclusions:

• ActD inhibits osteosarcoma cell proliferation and induces apoptosis through a mechanism involving reduced cyclin expression and cell cycle arrest.
• These findings offer a novel insight into ActD's action and suggest its potential as a therapeutic agent for osteosarcoma.